Syndromic and Point-of-Care Molecular Testing
| dc.contributor.author | Relich, Ryan F. | |
| dc.contributor.author | Abbott, April N. | |
| dc.contributor.department | Microbiology and Immunology, School of Medicine | en_US |
| dc.date.accessioned | 2020-05-15T21:41:43Z | |
| dc.date.available | 2020-05-15T21:41:43Z | |
| dc.date.issued | 2018-11 | |
| dc.description | This article is made available for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. | |
| dc.eprint.version | Final published version | en_US |
| dc.identifier.citation | Relich, R. F., & Abbott, A. N. (2018). Syndromic and point-of-care molecular testing. Advances in Molecular Pathology, 1(1), 97. https://doi.org/10.1016/j.yamp.2018.07.007 | en_US |
| dc.identifier.uri | https://hdl.handle.net/1805/22782 | |
| dc.language.iso | en | en_US |
| dc.publisher | Elsevier | en_US |
| dc.relation.isversionof | 10.1016/j.yamp.2018.07.007 | en_US |
| dc.relation.journal | Advances in Molecular Pathology | en_US |
| dc.rights | Publisher Policy | en_US |
| dc.rights | This article is made available for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. | |
| dc.source | Publisher | en_US |
| dc.subject | syndromic panels | en_US |
| dc.subject | point-of-care molecular diagnostics | en_US |
| dc.subject | influenza-like illness | en_US |
| dc.title | Syndromic and Point-of-Care Molecular Testing | en_US |
| dc.type | Article | en_US |